|
| Status |
Public on May 23, 2017 |
| Title |
EBC1-PR1 |
| Sample type |
genomic |
| |
|
| Source name |
Cell line with adquired resistance to MET tyrosine kinase inhibitors
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: EBC1 cells
cell type: lung cancer
phenotype: adquired resistance to MET tyrosine kinase inhibitors
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Total DNA was isolated by standard procedures
|
| Label |
Cy3, Cy5
|
| Label protocol |
Standard Illumina labelling protocol
|
| |
|
| Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Infinium MethylationEPIC Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using High Scan SQ using standard recommended Illumina scanner setting
|
| Data processing |
Genome Studio V2011.2
|
| |
|
| Submission date |
Dec 20, 2016 |
| Last update date |
May 23, 2017 |
| Contact name |
Sebastian Moran |
| Organization name |
IDIBELL
|
| Department |
PEBC
|
| Street address |
Av. Gran Via de l'Hospitalet, 199-203
|
| City |
L'Hospitalet del Llobregat |
| State/province |
Barcelona |
| ZIP/Postal code |
08908 |
| Country |
Spain |
| |
|
| Platform ID |
GPL21145 |
| Series (1) |
| GSE92608 |
Genomic and molecular screenings unveil different mechanisms for acquired resistance to MET inhibitors in lung cancer cells |
|
